Levy JA - Search Results

1

IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery.

Ndhlovu LC, Sinclair E, Epling L, Tan QX, Ho T, Jha AR, Eccles-James I, Tincati C, Levy JA, Nixon DF, Hecht FM, Barbour JD. Ndhlovu LC, et al. Among authors: levy ja. J Clin Immunol. 2010 Sep;30(5):681-92. doi: 10.1007/s10875-010-9432-3. Epub 2010 Jun 23. J Clin Immunol. 2010. PMID: 20571894 Free PMC article. Clinical Trial.

2

CD8+ cell anti-HIV activity rapidly increases upon discontinuation of early antiretroviral therapy.

Killian MS, Roop J, Ng S, Hecht FM, Levy JA. Killian MS, et al. Among authors: levy ja. J Clin Immunol. 2009 May;29(3):311-8. doi: 10.1007/s10875-009-9275-y. Epub 2009 Feb 3. J Clin Immunol. 2009. PMID: 19189205

3

High CD8+ T cell activation marks a less differentiated HIV-1 specific CD8+ T cell response that is not altered by suppression of viral replication.

Barbour JD, Ndhlovu LC, Xuan Tan Q, Ho T, Epling L, Bredt BM, Levy JA, Hecht FM, Sinclair E. Barbour JD, et al. Among authors: levy ja. PLoS One. 2009;4(2):e4408. doi: 10.1371/journal.pone.0004408. Epub 2009 Feb 9. PLoS One. 2009. PMID: 19198651 Free PMC article.

4

Effect of IL-2 therapy on CD8+ cell noncytotoxic anti-HIV response during primary HIV-1 infection.

Martinez-Mariño B, Ashlock BM, Shiboski S, Hecht FM, Levy JA. Martinez-Mariño B, et al. Among authors: levy ja. J Clin Immunol. 2004 Mar;24(2):135-44. doi: 10.1023/B:JOCI.0000019778.96564.26. J Clin Immunol. 2004. PMID: 15024180 Clinical Trial.

5

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narváez AB, Hunt P, Martin JN, Kahn JO, Levy J, McGrath MS, Hecht FM. Deeks SG, et al. Blood. 2004 Aug 15;104(4):942-7. doi: 10.1182/blood-2003-09-3333. Epub 2004 Apr 29. Blood. 2004. PMID: 15117761 Free article.

6

Interleukin-2 therapy restores CD8 cell non-cytotoxic anti-HIV responses in primary infection subjects receiving HAART.

Martinez-Mariño B, Shiboski S, Hecht FM, Kahn JO, Levy JA. Martinez-Mariño B, et al. Among authors: levy ja. AIDS. 2004 Oct 21;18(15):1991-9. doi: 10.1097/00002030-200410210-00003. AIDS. 2004. PMID: 15577620 Clinical Trial.

7

Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection.

Hare CB, Pappalardo BL, Busch MP, Karlsson AC, Phelps BH, Alexander SS, Bentsen C, Ramstead CA, Nixon DF, Levy JA, Hecht FM. Hare CB, et al. Among authors: levy ja. Clin Infect Dis. 2006 Mar 1;42(5):700-8. doi: 10.1086/500215. Epub 2006 Jan 23. Clin Infect Dis. 2006. PMID: 16447118

8

Killian MS, Fujimura SH, Hecht FM, Levy JA. Killian MS, et al. Among authors: levy ja. AIDS. 2006 Jun 12;20(9):1247-52. doi: 10.1097/01.aids.0000232231.34253.bd. AIDS. 2006. PMID: 16816552

9

The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody response.

Killian MS, Norris PJ, Rawal BD, Lebedeva M, Hecht FM, Levy JA, Busch MP. Killian MS, et al. Among authors: levy ja. AIDS Res Hum Retroviruses. 2006 Jul;22(7):640-7. doi: 10.1089/aid.2006.22.640. AIDS Res Hum Retroviruses. 2006. PMID: 16831088

10

Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression.

Barbour JD, Sriram U, Caillier SJ, Levy JA, Hecht FM, Oksenberg JR. Barbour JD, et al. Among authors: levy ja. PLoS Pathog. 2007 Apr;3(4):e43. doi: 10.1371/journal.ppat.0030043. PLoS Pathog. 2007. PMID: 17447840 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

605 results

Search Page

Filters